Difference between revisions of "Aortic stenosis"

From WikiAnesthesia
Tag: 2017 source edit
Tag: 2017 source edit
Line 93: Line 93:
==Epidemiology<!-- Describe the epidemiology of this comorbidity -->==
==Epidemiology<!-- Describe the epidemiology of this comorbidity -->==


[[Category:Comorbidity]]
[[Category:Comorbidities]]
[[Category:Cardiovascular disorders]]
[[Category:Cardiovascular disorders]]
[[Category:Valvular heart disease]]
[[Category:Valvular heart disease]]

Revision as of 09:19, 20 February 2021

Aortic stenosis
Severe aortic valve stenosis E00264 (CardioNetworks ECHOpedia).jpg
An echocardiogram showing a valve pressure gradient consistent with severe aortic stenosis
Anesthetic relevance

Critical

Anesthetic management

{{{anesthetic_management}}}

Specialty

Cardiology

Signs and symptoms

Angina, dyspnea, peripheral edema, syncope

Diagnosis

Echocardiogram

Treatment

Valve replacement surgery

Article quality
Editor rating
Comprehensive
User likes
0

Aortic stenosis is the narrowing of the outflow tract of the left ventricle due to calcification of the aortic valve.

Anesthetic implications

Preoperative optimization

Asymptomatic aortic stenosis may be initially detected on physical exam. Peripheral pulses may be weak and late (sometimes called pulsus parvus et tardus). A harsh systolic crescendo-decrescendo murmur may also be present, which is best heard at the right upper sternal border at the 2nd intercostal space. This murmur may also radiate to the carotid arteries.

Patients with suspected aortic stenosis should undergo Transthoracic echocardiogram to confirm the diagnosis and evaluate the severity of the disease. For severe disease, valve replacement therapy should be considered prior to proceeding with elective surgery.

Intraoperative management

Monitoring

Hemodynamics

  • Hypotension should be avoided to preserve afterload (i.e. coronary perfusion pressure). Treat with afterload-increasing agents such as phenylephrine.
  • Bradycardia should be avoided as these patients are often heart rate dependent to preserve adequate cardiac output. A heart rate of 60-90 bpm is optimal.
  • Tachycardia and hypertension should be avoided to preserve left ventricular diastolic filling and reduce myocardial oxygen demand. Treat with increasing anesthetic depth or short-acting beta-blockade with esmolol.

Neuraxial anesthesia

Neuraxial anesthesia is contraindicated in all but mild disease due to the risk of decreased systemic vascular resistance leading to decreased diastolic blood pressure and reduced myocardial perfusion

Postoperative management

Patients with significant disease may require close postoperative monitoring to quickly identify and manage any hemodynamic instability.

Related surgical procedures

Pathophysiology

In aortic stenosis, the opening of the aortic valve is narrowed, typically due to calcification from tissue damage over time. The most common cause is valve degeneration in older patients, though stenosis may develop in younger patients with a bicuspid aortic valve. It is thought that stenosis results from inflammation due to endothelial cell damage from increased mechanical stress.

As aortic stenosis progresses, higher pressures must be generated by the left ventricle to maintain cardiac output. This initially leads to the development of concentric left ventricular hypertrophy. In later stages of the disease, the left ventricle dilates and the ventricular walls thin, resulting in reduced systolic function.

Signs and symptoms

Signs

  • Slow/late peripheral pulses (pulsus parvus et tardus)
  • Harsh systolic crescendo-decrescendo murmur
    • Best auscultated at the right upper sternal border at the 2nd intercostal space
    • May radiate to both carotids
  • Decreased intensity of the second heart sound (A2)

Symptoms

Diagnosis

Severity of aortic stenosis
Degree Mean gradient
(mmHg)
Aortic valve area
(cm2)
Mild <25 >1.5
Moderate 25 - 40 1.0 - 1.5
Severe >40 < 1.0
Very severe >70 < 0.6

Aortic stenosis may be initially suspected from the physical exam findings described above. Definitive diagnosis and classification of disease severity can be determined using echocardiography or heart catheterization.

Treatment

Medication

In general, medication has poor efficacy in the treatment of aortic stenosis. However, medical therapy is important to manage concomitant cardiac diseases such as heart failure, hypertension and symptoms such as angina.

Surgery

Severe symptomatic aortic stenosis is typically treated with aortic valve replacement. For patients who are poor candidates for surgical valve replacement, transcatheter aortic valve replacement is an alternative. Balloon valvuloplasty is can be effective in infants and children, but has limited efficacy in adults since the valve generally returns to a stenosed state.

Prognosis

Untreated severe symptomatic aortic stenosis has a poor prognosis, with a 2-year survival rate of 50-60%. For patients who undergo valve replacement, life expectancy is about 5 years less than the general population for patients under 65, and similar to patients without aortic stenosis for patients over 65.

Epidemiology

References